Greek: Malliá (μαλλιά) = english hair
Mallia is a biopharmaceutical company focused on developing novel treatments to treat patients suffering from hair loss.
With the ground-breaking science and innovation based on more than 20 years of research, Mallia has identified sCD83 as key mediator, not only to stimulate hair follicles to regrow hair, but also to induce new hair growth.
We are about to initiate pre-clinical and clinical trials to evaluate the safety and efficacy of of sCD83 as well as obtaining all applicable regulatory approvals.
Mallias leadership team has extensive experience in the research and development of novel drugs and the management of start-up pharmaceutical companies